CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.68
Tradestie Score
54
Market Cap
$164.52M
Analyst Upside
+487.9%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.18
$711.32M - 54 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 59 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.50
$543.32M - 57 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.33
$237.15M 6.6 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$25.10
$212.23M - 55 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$2.65
$11.85M - 48 Compare
IBO Impact BioMedical, Inc.
$0.47
$7.84M - 48 Compare
AMIX Autonomix Medical, Inc. Common Stock
$6.43
$7.25M - 56 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$13.80
$6.53M - 54 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$0.46
$4.04M 0.0 46 Compare

Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry